Global
Asparaginase Market: Overview
Asparaginase
also known as crisantaspase, is an enzyme used in food and
pharmaceutical manufacturing. It is one of the medicine in the World
Health Organization's List of Essential Medicines, made from
bacterial species such as Erwinia chrysanthemi and Escherichia coli.
Asparaginase is used in the food manufacturing to reduce the
formation of acrylamide. Acrylamide is a carcinogen in the starch
containing food products such as biscuits and snacks. In
pharmaceuticals, Asparaginase is used to treat various diseases and
disorders such as non-Hodgkin's lymphoma, acute myeloid leukemia
(AML), and acute lymphoblastic leukemia (ALL). The North America
Asparaginase market accounts for relatively high revenue share,
followed by Western Europe Asparaginase market. Whereas, APEJ account
for relatively high volume share in global Asparaginase market with
significant growth rate.
Download
PDF Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=24116
Global
Asparaginase Market: Dynamics
Some
of the important factor fuelling the growth of global Asparaginase
market include growing pharmaceutical and food industry. To counter
the same, Asparaginase market players are investing in research and
development and production of Asparaginase to meet the regulatory
specification with increasing demand. Some macroeconomic factors
making a positive impact on global Asparaginase market includes
increasing population, the rapid rate of urbanization, and growing
domestic income. Major restraining factors for global Asparaginase
market are its side effect in human body pancreatitis, mild Bone
marrow suppression, anticoagulant factor resulting in the stroke and
bleeding, decreases protein synthesis and hypersensitivity or
allergic reaction. The trend identified in the global Asparaginase
market is mergers and acquisitions between Asparaginase producers and
finished product manufacturers such as pharmaceuticals and food. The
company manufacturing Asparaginase products has a significant
opportunity in regions such as North America, Europe, and Asia
Pacific, attributed to high demand for pharmaceuticals across the
regions. Companies have a significant opportunity in global
Asparaginase market through collaboration with end-users i.e. food
and pharmaceutical manufacturers.
Global
Asparaginase Market: Regional Overview
By
geographies, the global Asparaginase market is segmented into seven
regions -- North America, Western Europe, Asia-Pacific except Japan
(APEJ), Eastern Europe, Latin America, the Middle East & Africa,
and Japan. Among the regions, North America dominates the global
Asparaginase market in terms of value, owing to a significant revenue
share of the region in the pharmaceutical industry. Western Europe is
followed by North America in the global Asparaginase market,
attributed to rapidly rising demand for food and beverages across the
region. Eastern Europe and Japan also accounts for significant value
share in the global Asparaginase market. The APEJ is expected to
account for relatively high volume share in the global Asparaginase
market, owing to a relatively high growth rate of pharmaceutical and
food industry across the globe. Latin America and Middle East Africa
is expected to have relatively high opportunity for Asparaginase
market players, attributed to high growth rate of the healthcare
sector in the regions. Overall, the outlook for the global
Asparaginase market will have a positive growth over the forecast
period.
Buy
this Report at:
https://www.transparencymarketresearch.com/checkout.php?rep_id=24116<ype=S
Global
Asparaginase Market: Key Players
Few
players of Asparaginase market include Novus Biologicals, Taj
Pharmaceuticals Limited, Porton Biopharma, Xiamen Hisunny Chemical
Co., Ltd., Jinan Haohua Industry Co., Ltd., Simagchem Corporation,
LGM Pharma, Leap Labchem Co., Ltd., Hangzhou J&H Chemical Co.,
Ltd., Hangzhou Dayangchem Co. Ltd., Gihi Chemicals Co., Limited,
Chemos GmbH & Co. KG
No comments:
Post a Comment